Annovis Bio Statistics Share Statistics Annovis Bio has 19.49M
shares outstanding. The number of shares has increased by 49.27%
in one year.
Shares Outstanding 19.49M Shares Change (YoY) 49.27% Shares Change (QoQ) 0% Owned by Institutions (%) 11.97% Shares Floating 16.59M Failed to Deliver (FTD) Shares 282 FTD / Avg. Volume 0.09%
Short Selling Information The latest short interest is 1.71M, so 8.77% of the outstanding
shares have been sold short.
Short Interest 1.71M Short % of Shares Out 8.77% Short % of Float 10.23% Short Ratio (days to cover) 7.07
Valuation Ratios PE Ratio 0 Forward PE -2 PS Ratio 0 Forward PS 4.4 PB Ratio 6.58 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Annovis Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.59,
with a Debt / Equity ratio of 0.
Current Ratio 3.59 Quick Ratio 3.59 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -14.4
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.07B Employee Count 8 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -69.04% in the
last 52 weeks. The beta is 1.64, so Annovis Bio's
price volatility has been higher than the market average.
Beta 1.64 52-Week Price Change -69.04% 50-Day Moving Average 2.57 200-Day Moving Average 2.93 Relative Strength Index (RSI) 52.16 Average Volume (20 Days) 313,896
Income Statement
Revenue n/a Gross Profit n/a Operating Income -26.7M Net Income -24.59B EBITDA -22.74M EBIT -22.74M Earnings Per Share (EPS) -2018.5
Full Income Statement Balance Sheet The company has 10.55M in cash and 0 in
debt, giving a net cash position of 10.55M.
Cash & Cash Equivalents 10.55M Total Debt n/a Net Cash n/a Retained Earnings -134.85M Total Assets 21.45B Working Capital 14.33B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -21.89B
and capital expenditures 4, giving a free cash flow of -21.89B.
Operating Cash Flow -21.89B Capital Expenditures 4 Free Cash Flow -21.89B FCF Per Share -1797.29
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
